LFMDNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMDP
LifeMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$2.25−0.09 (-3.85%)
Close on Oct 19, 2026
- Market cap
- $107.52M
- P/E (TTM)
- –
- Dividend yield
- –
LifeMD, Inc. cash flow statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 86.1%
- Operating margin
- -14.7%
- Net margin
- 0.1%
- Return on equity, FY2025
- 204.0%
Financial strength
- Current ratio
- 0.90
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 53.9%
Valuation
- P/E ratio
- –
- Price to sales
- 0.65
- Price to book
- 13.50
- Dividend yield
- –